In a retrospective survey of 24 consecutive referrals to a hospital diabetic clinic of patients with type 2 diabetes and HbA1c > 7.5%, HbA1c at 6–12 months improved in those maintained on oral hypoglycaemics (initial 9.5% ± 1.1%, finl 8.0% ± 1.5%, n=10, p=0.02) and in those who were changed to insulin (initial 9.7% ± 1.4%, final 8.0% ± 1.5%, n=14 p= <0.01). Patients maintained on oral
... [Show full abstract] hypoglycaemics were significantly more overweight than those changed to insulin (BMI 35.0 ± 8.2 kg/m2 versus 27.3 ± 5.8 kg/m2, p <0.025). If patients who missed more than 30% of appointments (n=7) are excluded from the analysis, the outcome in HbA1c was similar to that achieved in the intensive arm of the UKPD Study.